Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance.
about
Continued lamivudine for adults with lamivudine-resistant chronic hepatitis B virus infectionAntiviral treatments for lamivudine-resistant chronic hepatitis B adult patientsGenetic variation of occult hepatitis B virus infectionCross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virusCharacterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model.Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assayComplex dynamics of hepatitis B virus resistance to adefovir.Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.Isolated anti-hbc and occult HBV infection in dialysis patientsEarly detection of hepatitis B drug resistance: implications for patient management.Mutations affecting the replication capacity of the hepatitis B virus.Performance of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantificationVirologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach.Molecular mechanisms underlying HBsAg negativity in occult HBV infection.Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy.Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.Novel nucleoside analogue MCC-478 (LY582563) is effective against wild-type or lamivudine-resistant hepatitis B virus.Antiviral activities of MCC-478, a novel and specific inhibitor of hepatitis B virus.The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro.Treatment of recurrent hepatitis B infection in liver transplant recipients.Amino acid polymorphism in the reverse transcriptase region of hepatitis B virus and the relationship with nucleos(t)ide analogues treatment for preventing mother-to-infant transmission.In vitro drug susceptibility analysis of hepatitis B virus clinical quasispecies populations.Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model.Comparative analysis of viral genomes from acute and chronic hepatitis B reveals novel variants associated with a lower rate of chronicity.Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1.Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus.Site-specific incorporation of nucleoside analogs by HIV-1 reverse transcriptase and the template grip mutant P157S. Template interactions influence substrate recognition at the polymerase active site.Characterization of the dynamics of hepatitis B virus resistance to adefovir by ultra-deep pyrosequencing.Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients.Characterization of naturally occurring and Lamivudine-induced surface gene mutants of hepatitis B virus in patients with chronic hepatitis B in India.Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China.
P2860
Q24185958-74E11CC2-7564-482C-BC2C-BFEA5CF1404AQ24241469-A5A2EED9-1B91-42A5-AD33-FCDB1D537E0CQ26751031-7D2B2039-26A9-486F-A12C-2654D821B11FQ28365198-B25305B6-BD5A-467E-9573-4AC0DBD55B85Q33978482-B5B00A15-730A-44E3-A82E-85DCA33B7114Q34200074-010454ED-85E7-442C-BA70-625C97A71D0DQ34208672-7E5783DC-F5C7-499F-84C5-9907AF75EFC3Q34299035-EDA7F045-44C9-4216-BB82-0F91450E1322Q35089849-2C8CD8ED-7B0C-4B43-AE0C-CAA40CA1619EQ35543876-514505C2-04CF-488B-930A-6C38D1129528Q36515349-5CBB3AB7-AE64-4B0E-A8A2-B9513A0CD996Q36673025-918BD6CB-AE3A-47D4-A90C-57E639F1EEFCQ37074608-532AC0E2-06A2-4E1D-8C99-285FF419EB9CQ38536404-C6BBFAD5-FBEC-449C-84FC-1767335D9A93Q39455322-781E6E41-0850-4D59-8788-6553B2C26F03Q39602136-D83AB14D-EF49-4939-9D3D-28708CAA5BCAQ39652342-A00A5F62-19AB-43B2-AB58-9354D2D197E8Q39652664-CE09672C-9CB3-406D-8880-3BC1BC9F0C44Q40012022-E7898F97-B4CA-4EAD-815E-76002644363AQ40629253-FFD186A0-0D96-4113-A345-3A256E0CF645Q42217478-8F1B0EFC-B5A8-471A-8FDB-1FD4BB085FA8Q42637962-67FD6495-B29F-40ED-BB58-8AF43AE2D9ACQ43653268-F1ECB615-73B0-49C4-84B5-D20A81091F53Q43717709-5E3A1432-C02A-445A-B284-2539444C2135Q43792563-79F846DF-AAE1-4908-A222-032A841224DFQ44134176-3BD60AE3-7205-4ECB-9B51-68540B6E88E7Q44225811-5490D55C-892A-4F1E-9045-B309C09B7987Q44675493-C2D394FD-9661-4C9D-B9D5-A82C1B36202CQ45227673-3D970FA2-B7D9-4909-8456-214507CC57B9Q45420569-23F94842-91BD-4CE4-8EB4-4404053E35E6Q48053718-A417C102-D061-4CC2-8BA7-B9B8072891F3
P2860
Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Transient selection of a hepat ...... ty and famciclovir resistance.
@en
Transient selection of a hepat ...... ty and famciclovir resistance.
@nl
type
label
Transient selection of a hepat ...... ty and famciclovir resistance.
@en
Transient selection of a hepat ...... ty and famciclovir resistance.
@nl
prefLabel
Transient selection of a hepat ...... ty and famciclovir resistance.
@en
Transient selection of a hepat ...... ty and famciclovir resistance.
@nl
P2093
P2860
P356
P1433
P1476
Transient selection of a hepat ...... ty and famciclovir resistance.
@en
P2093
P2860
P304
P356
10.1002/HEP.510290119
P407
P577
1999-01-01T00:00:00Z